Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant in Spinal Anaesthesia for Total Knee Arthroplasty
NCT02966249Phase 4Unknown
- Sponsor
- KAT General Hospital
- Start
- Oct 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in total knee arthroplasty (TKA) (3 arms), sponsored by KAT General Hospital. Primary endpoints: Onset of sensory block, Duration of sensory block and 3 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
total knee arthroplasty (TKA)
Beyond the preview
Go deeper on NCT02966249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966249.